Changes in cochlear blood flow due to intra-arterial infusions of angiotensin II (3-8) (angiotensin IV) in guinea pigs

John K M Coleman, Janet I. Lee, Josef M. Miller, Alfred Nuttall

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The effects of a newly discovered form of angiotensin, angiotensin IV (ANGIV), on cochlear blood flow (CBF) have been investigated utilizing the laser Doppler flowmetry (LDF) technique. Two specific questions were addressed: What are the effects of anterior inferior cerebellar artery infusions (AICA) of ANGIV on CBF and do angiotensin fragments other than ANGIV influence CBF in mature male and female guinea pigs. Infusions of ANGIV, and C-terminal shortened fragments were accomplished via micropipette into the AICA and changes in CBF were observed using LDF. The results demonstrated that 10 and 100 pmol/min doses of ANGIV increased CBF 22% and 75% (n = 6; P <0.01) from baseline, respectively, with little change in mean arterial blood pressure (MAP). Pretreatment with the ANGIV antagonist divalanal-ANGIV (1 nmole/min) blocked increases in CBF due to infusions of 100 pmol/min of ANGIV. The infusion of the C-terminal shortened fragment ANGIV(1-5) and saline had no significant effect on either CBF or MAP. These results provide the evidence for a new subtype of the angiotensin receptor and indicate the likely role of circulating hormones in blood flow regulation in the inner ear.

Original languageEnglish (US)
Pages (from-to)61-68
Number of pages8
JournalHearing Research
Volume119
Issue number1-2
DOIs
StatePublished - May 1998

Fingerprint

Intra Arterial Infusions
Cochlea
Guinea Pigs
Arterial Pressure
Laser-Doppler Flowmetry
Angiotensins
Arteries
Angiotensin Receptors
des-Asp(1)-des-Arg(2)-Ile(5)-angiotensin II
Inner Ear
Hormones

Keywords

  • Angiotensin
  • Blood flow
  • Cochlea
  • Guinea pig
  • Hearing
  • Microcirculation

ASJC Scopus subject areas

  • Sensory Systems

Cite this

Changes in cochlear blood flow due to intra-arterial infusions of angiotensin II (3-8) (angiotensin IV) in guinea pigs. / Coleman, John K M; Lee, Janet I.; Miller, Josef M.; Nuttall, Alfred.

In: Hearing Research, Vol. 119, No. 1-2, 05.1998, p. 61-68.

Research output: Contribution to journalArticle

@article{8707ce070eb046559d25bd57c3ee4d23,
title = "Changes in cochlear blood flow due to intra-arterial infusions of angiotensin II (3-8) (angiotensin IV) in guinea pigs",
abstract = "The effects of a newly discovered form of angiotensin, angiotensin IV (ANGIV), on cochlear blood flow (CBF) have been investigated utilizing the laser Doppler flowmetry (LDF) technique. Two specific questions were addressed: What are the effects of anterior inferior cerebellar artery infusions (AICA) of ANGIV on CBF and do angiotensin fragments other than ANGIV influence CBF in mature male and female guinea pigs. Infusions of ANGIV, and C-terminal shortened fragments were accomplished via micropipette into the AICA and changes in CBF were observed using LDF. The results demonstrated that 10 and 100 pmol/min doses of ANGIV increased CBF 22{\%} and 75{\%} (n = 6; P <0.01) from baseline, respectively, with little change in mean arterial blood pressure (MAP). Pretreatment with the ANGIV antagonist divalanal-ANGIV (1 nmole/min) blocked increases in CBF due to infusions of 100 pmol/min of ANGIV. The infusion of the C-terminal shortened fragment ANGIV(1-5) and saline had no significant effect on either CBF or MAP. These results provide the evidence for a new subtype of the angiotensin receptor and indicate the likely role of circulating hormones in blood flow regulation in the inner ear.",
keywords = "Angiotensin, Blood flow, Cochlea, Guinea pig, Hearing, Microcirculation",
author = "Coleman, {John K M} and Lee, {Janet I.} and Miller, {Josef M.} and Alfred Nuttall",
year = "1998",
month = "5",
doi = "10.1016/S0378-5955(98)00038-0",
language = "English (US)",
volume = "119",
pages = "61--68",
journal = "Hearing Research",
issn = "0378-5955",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Changes in cochlear blood flow due to intra-arterial infusions of angiotensin II (3-8) (angiotensin IV) in guinea pigs

AU - Coleman, John K M

AU - Lee, Janet I.

AU - Miller, Josef M.

AU - Nuttall, Alfred

PY - 1998/5

Y1 - 1998/5

N2 - The effects of a newly discovered form of angiotensin, angiotensin IV (ANGIV), on cochlear blood flow (CBF) have been investigated utilizing the laser Doppler flowmetry (LDF) technique. Two specific questions were addressed: What are the effects of anterior inferior cerebellar artery infusions (AICA) of ANGIV on CBF and do angiotensin fragments other than ANGIV influence CBF in mature male and female guinea pigs. Infusions of ANGIV, and C-terminal shortened fragments were accomplished via micropipette into the AICA and changes in CBF were observed using LDF. The results demonstrated that 10 and 100 pmol/min doses of ANGIV increased CBF 22% and 75% (n = 6; P <0.01) from baseline, respectively, with little change in mean arterial blood pressure (MAP). Pretreatment with the ANGIV antagonist divalanal-ANGIV (1 nmole/min) blocked increases in CBF due to infusions of 100 pmol/min of ANGIV. The infusion of the C-terminal shortened fragment ANGIV(1-5) and saline had no significant effect on either CBF or MAP. These results provide the evidence for a new subtype of the angiotensin receptor and indicate the likely role of circulating hormones in blood flow regulation in the inner ear.

AB - The effects of a newly discovered form of angiotensin, angiotensin IV (ANGIV), on cochlear blood flow (CBF) have been investigated utilizing the laser Doppler flowmetry (LDF) technique. Two specific questions were addressed: What are the effects of anterior inferior cerebellar artery infusions (AICA) of ANGIV on CBF and do angiotensin fragments other than ANGIV influence CBF in mature male and female guinea pigs. Infusions of ANGIV, and C-terminal shortened fragments were accomplished via micropipette into the AICA and changes in CBF were observed using LDF. The results demonstrated that 10 and 100 pmol/min doses of ANGIV increased CBF 22% and 75% (n = 6; P <0.01) from baseline, respectively, with little change in mean arterial blood pressure (MAP). Pretreatment with the ANGIV antagonist divalanal-ANGIV (1 nmole/min) blocked increases in CBF due to infusions of 100 pmol/min of ANGIV. The infusion of the C-terminal shortened fragment ANGIV(1-5) and saline had no significant effect on either CBF or MAP. These results provide the evidence for a new subtype of the angiotensin receptor and indicate the likely role of circulating hormones in blood flow regulation in the inner ear.

KW - Angiotensin

KW - Blood flow

KW - Cochlea

KW - Guinea pig

KW - Hearing

KW - Microcirculation

UR - http://www.scopus.com/inward/record.url?scp=0032080537&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032080537&partnerID=8YFLogxK

U2 - 10.1016/S0378-5955(98)00038-0

DO - 10.1016/S0378-5955(98)00038-0

M3 - Article

VL - 119

SP - 61

EP - 68

JO - Hearing Research

JF - Hearing Research

SN - 0378-5955

IS - 1-2

ER -